Abstract
Coronavirus disease 2019 (COVID-19) is impacting our daily practice. Hematologist and oncologist around the globe are concerned and many physicians are hesitating to start/continue antineoplastic treatment in patients with cancer to protect them from severe complications in case of infection with the new novel corona virus. Therefore, we feel there is a high demand for scoring system to guide and help physicians dealing with patients with malignant diseases to take the correct decision. We have designed a scoring system to evaluate patients with cancer requiring anti-cancer treatment and we have started to implement it at our hospital. Therefore, we would like to share this scoring system with the community.
Highlights
Scoring SystemVast majority of world countries are still reporting on significant number of new patients infected daily with the new virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Coronavirus disease 2019 (COVID-19) is impacting our daily practice
We feel there is a high demand for scoring system to guide and help physicians dealing with patients with malignant diseases to take the correct decision
Summary
Vast majority of world countries are still reporting on significant number of new patients infected daily with the new virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There have been different recommendations from several hematology/oncology societies on how to handle cancer patients in need of anti-neoplastic treatment during the outbreak of COVID-19. In attempt to simplify decision making for our physicians treating patients with cancer, we designed a scoring system to assess and balance the risks and benefits of chemotherapy in patients with cancer during outbreak of COVID-19. This scoring system is taking in consideration many factors including patients’ related factors, treatment type, hospital related issues and others. The benefits of systemic chemotherapy during COVID-19 outbreak do not overweigh the risks of complications in case patients got infected with the new Corona virus. Patients shall be evaluated every 4-8 weeks and the scoring system might be applied again to re-evaluate treatment decision
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
